1. Home
  2. ELVN vs BELFB Comparison

ELVN vs BELFB Comparison

Compare ELVN & BELFB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ELVN
  • BELFB
  • Stock Information
  • Founded
  • ELVN 2016
  • BELFB 1949
  • Country
  • ELVN United States
  • BELFB United States
  • Employees
  • ELVN N/A
  • BELFB N/A
  • Industry
  • ELVN Biotechnology: Pharmaceutical Preparations
  • BELFB
  • Sector
  • ELVN Health Care
  • BELFB
  • Exchange
  • ELVN Nasdaq
  • BELFB Nasdaq
  • Market Cap
  • ELVN 927.8M
  • BELFB 865.9M
  • IPO Year
  • ELVN 2020
  • BELFB N/A
  • Fundamental
  • Price
  • ELVN $17.77
  • BELFB $73.80
  • Analyst Decision
  • ELVN Strong Buy
  • BELFB Strong Buy
  • Analyst Count
  • ELVN 4
  • BELFB 3
  • Target Price
  • ELVN $37.25
  • BELFB $98.33
  • AVG Volume (30 Days)
  • ELVN 361.5K
  • BELFB 78.9K
  • Earning Date
  • ELVN 05-14-2025
  • BELFB 07-23-2025
  • Dividend Yield
  • ELVN N/A
  • BELFB 0.38%
  • EPS Growth
  • ELVN N/A
  • BELFB N/A
  • EPS
  • ELVN N/A
  • BELFB 3.42
  • Revenue
  • ELVN N/A
  • BELFB $558,940,000.00
  • Revenue This Year
  • ELVN N/A
  • BELFB $18.21
  • Revenue Next Year
  • ELVN N/A
  • BELFB $7.91
  • P/E Ratio
  • ELVN N/A
  • BELFB $21.25
  • Revenue Growth
  • ELVN N/A
  • BELFB N/A
  • 52 Week Low
  • ELVN $13.30
  • BELFB $58.00
  • 52 Week High
  • ELVN $30.03
  • BELFB $92.61
  • Technical
  • Relative Strength Index (RSI)
  • ELVN 49.54
  • BELFB 51.90
  • Support Level
  • ELVN $15.81
  • BELFB $71.75
  • Resistance Level
  • ELVN $17.54
  • BELFB $74.61
  • Average True Range (ATR)
  • ELVN 1.30
  • BELFB 2.66
  • MACD
  • ELVN -0.04
  • BELFB -0.25
  • Stochastic Oscillator
  • ELVN 38.06
  • BELFB 40.34

About ELVN Enliven Therapeutics Inc.

Enliven Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery and development of small molecule therapeutics. Its product candidates include ELVN-001 is designed to specifically target the BCR-ABL fusion gene product, the oncogenic driver for patients with chronic myeloid leukemia (CML), ELVN-002 is designed to inhibit wild-type HER2 and key mutations of HER2.

About BELFB Bel Fuse Inc. Class B

Bel Fuse Inc designs and manufactures electronic components that protect and connect electronic circuits. Its product portfolio is divided into three categories: magnetic solutions, power solutions & protection, and connectivity solutions. These products are used for the computer, networking, telecommunications, transportation and defense/aerospace, automotive, medical, and consumer electronics industries. Its geographical segments are the United States, Macao, United Kingdom, Slovakia, Germany, Switzerland, and All other foreign countries. Majority of the revenue is derived from United States.

Share on Social Networks: